MEDIGENE
Live / Registered — Registered (as of 17 Dec 2019)
What this means for you
Registered since 17 Dec 2019. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79250188
- Registration number
- 5934628
- Mark type
- Word mark
- Filed
- 17 Jul 2018
- Published for opposition
- 01 Oct 2019
- Registered
- 17 Dec 2019
- Attorney of record
- Lisa C. Pavento
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical and veterinary preparations namely, cellular preparations, T-cell preparations and DC (dendritic cell) preparations for the treatment of cancer and use in immunotherapy; medical compositions for the treatment of hematological and solid tumors, tumor precursors; test kits for diagnostic preparations for medical purposes for determining the type and existence of a tumor in a patient consisting primarily of antibodies, test kits for diagnostic preparations for medical purposes for determining the type and existence of a tumor in a patient consisting primarily of soluble T-cell receptors, test kits for diagnostic preparations for medical purposes for determining the type and existence of a tumor in a patient consisting primarily of genetically modified cells and test kits for diagnostic preparations for medical purposes for determining the type and existence of a tumor in a patient consisting of a composition of antibodies, soluble T-cell receptors and genetically modified cells; diagnostic and therapeutic preparations for medical purposes being mixtures of therapeutically active cells in a suitable medium, in particular produced using molecular biological, biotechnological and genetic methods
- Class 042 — Scientific and technological services: Services in molecular biology, namely, research and development in the field of medical and veterinary diagnosis and treatment using molecular biological, biotechnological and genetic methods, and in the field of screening for compounds with pharmaceutical properties; development of test methods and test kits in the field of hematological and solid tumor immunology; biological cell analyses; development of individualized medicine, development of treatment plans and therapy adapted for individual patients; all the foregoing being for scientific and therapeutic purposes; development of adoptive T cell therapy; development of DC vaccines; development of cellular tumour therapy; development of tumour markers; development of diagnostic and therapeutic antibodies; cell analyses; development of individualised medicine, development of treatment plans and therapy adapted for individual patients
- Class 044 — Medical, beauty and agricultural services: Medical and veterinary medical services, in particular extracting of blood and/or tissue samples and analysis and evaluation relating thereto for medical purposes
Owner
Prosecution history
- 17 Dec 2024 — COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
- 04 Aug 2022 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 04 Aug 2022 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 04 Aug 2022 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 04 Aug 2022 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 04 Aug 2022 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 01 May 2020 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 28 Mar 2020 — FINAL DISPOSITION NOTICE SENT TO IB
- 28 Mar 2020 — FINAL DISPOSITION PROCESSED
- 17 Mar 2020 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 17 Dec 2019 — REGISTERED-PRINCIPAL REGISTER
- 05 Oct 2019 — NOTIFICATION PROCESSED BY IB
- 01 Oct 2019 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 01 Oct 2019 — PUBLISHED FOR OPPOSITION
- 18 Sept 2019 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB